iShares U.S. Healthcare ETF News - July 18, 2026

Eli Lilly buys AtaiBeckley for $3.8B, expanding into psychedelic depression treatments

Eli Lilly agreed to acquire clinical-stage AtaiBeckley for up to $3.8 billion. The transaction consists of a $2.8 billion upfront cash payment and up to $1...